Search Results
State of the Art: Clinical Pharmacology of INSTI | Andrea Calcagno, MD, DTM&H
Virological and Pharmacological monitoring: How and how often? | Andrea Calcagno, MD, DTM&H
Preview of Drug-Drug Interactions with Oral INSTI | Andrea Calcagno, MD, DTM&H
Pharmacological Considerations in Choice of Regimen - Andrea Calcagno, MD, DTM&H
Clinical Implications of Long-Acting Antivirals - Andrea Calcagno
Switching ARV therapy - clinical and pharmacological considerations - Andrea Calcagno
Last advances in HIV pharmacogenomics | Andrea Calcagno, MD, DTM&H
Online Meeting Highlights | 3 | Clinical Pharmacology of Drugs for HIV Prevention & Treatment
Second Generation INSTI Regimens for Drug Naive Patients: State-of-the-Art | Daniel Kuritzkes, MD
Clinical Pharmacology of Integrase Inhibitors | Giovanni Di Perri, MD, PhD
Round Table Discussion 3 | Clinical Implementation of Long-Acting Therapies
State of the Art: Resistance to INSTI | Anne-Geneviève Marcelin, PharmD, PhD,
